Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
ERJ Open Research
Published September 1, 2026
Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis.
October 2, 2026
Medspoke
Medspoke
Circulation
Published October 1, 2026
00:00
--:--
Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement...
October 2, 2026
Share
Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement From the American Heart Association.
https://www.medspoke.co/channel_journal?id=678&tap_id=14910
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
European Journal of Heart Failure
Published October 1, 2026
Determinants and associations of health-related quality of life with mortality in acute and chron...
October 2, 2026
Why are you reporting this TALK?
